Table 4.
Cohort study quality.
| Research question clear? | Participant eligibility criteria clear? (without date and names) | Were participants representative of general population of interest? | Were all eligible participants enrolled? | Was sample size sufficient to provide confidence in the findings? | Was the intervention clearly described and delivered consistently? | Outcome measures clear, reliable and valid? Implemented consistently? | Blinded assessment of FMD? | Loss to follow-up after baseline <20% | Did the statistical method examine changes pre and post intervention? | |
|---|---|---|---|---|---|---|---|---|---|---|
| Grace et al., 2015 | Y | Y | Y | Y | Y | Y | Y | NR | Y | Y |
| Klonizakis et al., 2014 | Y | Y | Y | Y | CD | Y | Y | NR | Y | Y |
| Thijssen et al., 2007 | Y | Y | Y | Y | Y | Y | Y | NR | Y | Y |
Study quality assessment of the cohort studies included in question 2 developed by the National Heart, Lung and Blood Institute (NHLBI) (Quality Assessment Tool for Before-After (Pre-Post) Studies With No Control Group, 2014). Y, yes; N, no; NR, not reported; CD, cannot determine.